Blue Cross Accuses Boehringer, Teva Of Pay-For-Delay Deal
Blue Cross and Blue Shield of Louisiana accused Boehringer Ingelheim Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. on Tuesday in Connecticut federal court of violating antitrust laws through a pay-for-delay deal...To view the full article, register now.
Already a subscriber? Click here to view full article